SD
Therapeutic Areas
Sera Prognostics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| PreTRM® Test | Risk assessment for spontaneous preterm birth in asymptomatic singleton pregnancies | Approved/Commercial |
| LikeMine™ Platform | Pregnancy outcomes data analytics and personalized insights platform | Commercial/Development |
| Clock Proteins Research | Biomarker research for improved term delivery date prediction | Research/Proof-of-Concept |
Leadership Team at Sera Prognostics
GC
Gregory C. Davis
President, Chief Executive Officer, and Director
JM
Jay Moyes
Chief Financial Officer
AP
Andrew P. Mazar
Chief Scientific Officer
MA
Melissa A. Barnes
Chief Legal Officer and Corporate Secretary
RG
Robert G. Harrison
Chief Operating Officer